For citations:
Bessonov I.S., Shadrin A.A., Sapozhnikov S.S., Ryabov V.V., Popov S.V. Preventive use of glycoprotein IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction and a high risk of no-reflow phenomenon. Siberian Journal of Clinical and Experimental Medicine. 2023;38(2):122-131. (In Russ.) https://doi.org/10.29001/2073-8552-2023-38-2-122-131